Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...

LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by ...

Deaths from Staphylococcus aureus–associated lower respiratory tract infections tripled from 1990 to 2021 worldwide.

Nasal carriers of Staphylococcus aureus are at increased risk for health care–associated infections with this organism. Decolonization of nasal and extranasal sites on hospital admission may reduce ...

Pharmacal issued a recall for Multi-symptom Treatment Cream & Skin Protectant Eczema Cream for being potentially life-threatening for users.

Staphylococcus aureus (S. aureus) is one of the leading causes of infections acquired in the community and after surgery or hospital. Around 30% of individuals carry S. aureus in their nose, pharynx ...

Having a diverse mix of bacteria on your skin may help fight off eczema. The finding suggests that microbiome transplants could be a way to treat the skin condition. Eczema, or atopic dermatitis, ...

A research team discovers that silver (Ag)-based antimicrobials can effectively combat antibiotic resistant Staphylococcus aureus by targeting multiple biological pathways via functional disruption of ...